Psoriatic Arthritis (PsA) Treatment Market Report

Global and Region Psoriatic Arthritis (PsA) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：203
  • REPORT CODE：GMM987425
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Psoriatic Arthritis (PsA) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Psoriatic Arthritis (PsA) Treatmentmarket, defines the market attractiveness level of Psoriatic Arthritis (PsA) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Psoriatic Arthritis (PsA) Treatment industry, describes the types of Psoriatic Arthritis (PsA) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Psoriatic Arthritis (PsA) Treatment market and the development prospects and opportunities of Psoriatic Arthritis (PsA) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Psoriatic Arthritis (PsA) Treatment market in Chapter 13.

    By Player:

    • Amgen Inc

    • Johnson & Johnson Services Inc

    • Bausch Health Companies Inc

    • AbbVie Inc

    • Novartis International AG

    • AstraZeneca plc

    • Celgene Corporation

    By Type:

    • Nonsteriodal Anti-inflammatory Drugs

    • Disease Modifying Antirheumatic Drugs

    • Biologics

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Psoriatic Arthritis (PsA) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Psoriatic Arthritis (PsA) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Psoriatic Arthritis (PsA) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Psoriatic Arthritis (PsA) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Psoriatic Arthritis (PsA) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 7.2 United States Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 7.3 Europe Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 7.4 China Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 7.5 Japan Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 7.6 India Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    • 7.7 South Korea Psoriatic Arthritis (PsA) Treatment Consumption (2017-2022)

    8 Region and Country-wise Psoriatic Arthritis (PsA) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Psoriatic Arthritis (PsA) Treatment Consumption Forecast (2022-2028)

    9 Global Psoriatic Arthritis (PsA) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Nonsteriodal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Disease Modifying Antirheumatic Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Biologics Consumption and Growth Rate (2017-2022)

    • 9.2 Global Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Psoriatic Arthritis (PsA) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Nonsteriodal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Disease Modifying Antirheumatic Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Biologics Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Psoriatic Arthritis (PsA) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Psoriatic Arthritis (PsA) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Psoriatic Arthritis (PsA) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Psoriatic Arthritis (PsA) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Psoriatic Arthritis (PsA) Treatment Market Competitive Analysis

    • 14.1 Amgen Inc

      • 14.1.1 Amgen Inc Company Details

      • 14.1.2 Amgen Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Amgen Inc Psoriatic Arthritis (PsA) Treatment Product and Service

    • 14.2 Johnson & Johnson Services Inc

      • 14.2.1 Johnson & Johnson Services Inc Company Details

      • 14.2.2 Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Product and Service

    • 14.3 Bausch Health Companies Inc

      • 14.3.1 Bausch Health Companies Inc Company Details

      • 14.3.2 Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Product and Service

    • 14.4 AbbVie Inc

      • 14.4.1 AbbVie Inc Company Details

      • 14.4.2 AbbVie Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AbbVie Inc Psoriatic Arthritis (PsA) Treatment Product and Service

    • 14.5 Novartis International AG

      • 14.5.1 Novartis International AG Company Details

      • 14.5.2 Novartis International AG Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novartis International AG Psoriatic Arthritis (PsA) Treatment Product and Service

    • 14.6 AstraZeneca plc

      • 14.6.1 AstraZeneca plc Company Details

      • 14.6.2 AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Product and Service

    • 14.7 Celgene Corporation

      • 14.7.1 Celgene Corporation Company Details

      • 14.7.2 Celgene Corporation Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Celgene Corporation Psoriatic Arthritis (PsA) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Psoriatic Arthritis (PsA) Treatment

    • Figure Psoriatic Arthritis (PsA) Treatment Picture

    • Table Global Psoriatic Arthritis (PsA) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Psoriatic Arthritis (PsA) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Psoriatic Arthritis (PsA) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Psoriatic Arthritis (PsA) Treatment Consumption by Country (2017-2022)

    • Figure United States Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Psoriatic Arthritis (PsA) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Psoriatic Arthritis (PsA) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Psoriatic Arthritis (PsA) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nonsteriodal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Disease Modifying Antirheumatic Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Biologics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Nonsteriodal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Disease Modifying Antirheumatic Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Psoriatic Arthritis (PsA) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Psoriatic Arthritis (PsA) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Psoriatic Arthritis (PsA) Treatment Product and Service

    • Table Johnson & Johnson Services Inc (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Services Inc Psoriatic Arthritis (PsA) Treatment Product and Service

    • Table Bausch Health Companies Inc (Foundation Year, Company Profile and etc.)

    • Table Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch Health Companies Inc Psoriatic Arthritis (PsA) Treatment Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Psoriatic Arthritis (PsA) Treatment Product and Service

    • Table Novartis International AG (Foundation Year, Company Profile and etc.)

    • Table Novartis International AG Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG Psoriatic Arthritis (PsA) Treatment Product and Service

    • Table AstraZeneca plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc Psoriatic Arthritis (PsA) Treatment Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Psoriatic Arthritis (PsA) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Psoriatic Arthritis (PsA) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US